Advertisement

Klinische Wochenschrift

, Volume 68, Issue 8, pp 431–435 | Cite as

Persistent atrioventricular block in Lyme borreliosis

  • W. Mayer
  • F. X. Kleber
  • B. Wilske
  • V. Preac-Mursic
  • W. Maciejewski
  • H. Sigl
  • E. Holzer
  • W. Doering
Case Reports

Summary

Cardiac manifestations are reported in 0.3%–4.0% of European patients withBorrelia burgdorferi (B.b.) infection. Usually symptoms disappear within 6 weeks. We report a case with persistent impairment of atrioventricular (AV) conduction. Diagnosis was confirmed by demonstration of IgM antibodies and increase of IgG antibody titers against B.b. in serum, by isolation of the spirochete from skin biopsy material and by the typical clinical combination of erythema migrans, Bannwarth syndrome (meningoradiculitis), and complete heart block. Despite immediate antibiotic therapy with ceftriaxone, first degree AV block and second degree block Wenckebach with atrial pacing at 100 beats/minute persisted for 2 years. We conclude, that Lyme carditis can cause long-standing or irreversible AV conduction defects despite adequate and early antimicrobial therapy.

Key words

Lyme borreliosis Borrelia burgdorferi spirochete Lyme carditis Atrioventricular block 

Abbreviations

AV

atrioventricular

AVt

atrioventricular time

B. burgdorferi

Borrelia burgdorferi

CSF

cerebrospinal fluid

ECG

electrocardiogram

ESR

erythrocyte sedimentation rate

FRG

Federal Republic of Germany

I. dammini/ricinus

Ixodes dammini/ricinus

IgG

immunoglobulin G

IgM

immunoglobulin M

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Ackermann R (1986) Erythema-migrans-Borreliose und Frühsommer-Meningoenzephalitis. Deutsches ärzteblatt 83:1765–1774Google Scholar
  2. 2.
    Aeschlimann A, Chamot E, Gigon F, Jeanneret JP, Kesseler D, Walther C (1986) B. burgdorferi in Switzerland. Zbl Bakt Hyg A 263:450–458Google Scholar
  3. 3.
    Barbour AG (1989) The diagnosis of Lyme disease: rewards and perils. Ann Intern Med 110:501–502Google Scholar
  4. 4.
    Burgdorfer W, Barbour AG, Hayes SF, Benach JL, Grunwald E, Davis JP (1982) Lyme disease: a tick-borne spirochetosis. Science 216:1317–1319Google Scholar
  5. 5.
    Dattwyler RJ, Halperin JJ, Volkmann DJ, Luft BJ (1988) Treatment of late Lyme borreliosis — randomised comparison of ceftriaxone and penicillin. Lancet II: 1191–1194Google Scholar
  6. 6.
    Fahrer H, Sauvain MJ, von den Linden S, Zhioua E, Gern L, Aeschliman A (1988) Prävalenz der Lyme-Borreliose in einer schweizerischen Risikopopulation. Schweiz med Wochenschr 118:65–69Google Scholar
  7. 7.
    Hansen K, Madsen JK (1986) Myocarditis associated with tick-borneBorrelia burgdorferi infection. Lancet 1:1323–1324Google Scholar
  8. 8.
    Herzer P, Wilske B, Preac-Mursic V, Schierz G, Schattenkirchner M, Zöllner N (1986) Lyme arthritis: clinical features, serological, and radiographic findings of cases in Germany. Klin Wochenschr 64:206–215Google Scholar
  9. 9.
    Johnson RC, Kodner C, Russell M (1987) In vitro and in vivo suspectibility of the Lyme disease spirochete,Borrelia burgdorferi, to four antimicrobial agents. Antimicrobic Agents Chemother 31:164–167Google Scholar
  10. 10.
    Kohlhepp W, Mertens HG, Oschman P, Rohrbach E (1987) Akute und chronische Erkrankungen bei zeckenvermittelter Borreliose. Nervenarzt 58:557–563Google Scholar
  11. 11.
    Lyme Disease — United States 1980 (1981) MMWR 30:489–497Google Scholar
  12. 12.
    Marcus LC, Steere AC, Duray PH, Anderson AE, Mahoney EB (1985) Fatal pancarditis in a patient with coexistent lyme disease and Babesiosis. Ann Intern Med 103:374–376Google Scholar
  13. 13.
    McAlister HF, Klementowicz PT, Andrews C, Fisher JD, Feld M, Furman S (1989) Lyme carditis: an important cause of reversible heart block. Ann Intern Med 110:339–345Google Scholar
  14. 14.
    Muhlemann MF, Wright DJM (1987) Emerging pattern of Lyme disease in the United Kingdom and Irish Republic. Lancet I:260–262Google Scholar
  15. 15.
    Mursic VP, Wilske B, Schierz G, Holmburger M, Sü\ E (1987) In vitro and in vivo susceptibility ofBorrelia burgdorferi. Eur J Clin Microbiol 6:424–426Google Scholar
  16. 16.
    Olson LJ, Okafor EC, Clements IP (1986) Cardiac involvement in Lyme disease: manifestations and management. Mayo Clin Proc 61:745–749Google Scholar
  17. 17.
    Paul H, Gerth H-J, Ackermann R (1986) Infectiousness for humans ofIxodes ricinus containingBorrelia burgdorferi. Zbl Bakt Hyg A 263:473–476Google Scholar
  18. 18.
    Pfister HW (1988) Wie wird die neurologisch manifeste Lyme-Borreliose behandelt? Nervenarzt 59:687–689Google Scholar
  19. 19.
    Pfister HW, Einhäupl KM (1986) Lyme Borreliose — eine durchBorrelia burgdorferi hervorgerufene Multisystemerkrankung. Internistische Welt 3:76–84Google Scholar
  20. 20.
    Reznick JW, Braunstein DB, Walsh RL, Smith CR, Wolfson PM, Gierke LW, Gorelkin L, Chandler FW (1986) Lyme carditis. Electrophysiologic and histopathologic study. Am J Med 5:923–927Google Scholar
  21. 21.
    Satz N, Ackermann R, Gern L, Aeschlimann A, Ott A, Knoblauch M (1988) Zur Epidemiologie der Infektion mitBorrelia burgdorferi. Schweiz med Wochenschr 118:422–426Google Scholar
  22. 22.
    Schmidt R, Kabatzki J, Hartung S, Ackermann R (1986) Erythema chronicum migrans disease in the Federal Republic of Germany. Zbl Bakt Hyg A 263:435–441Google Scholar
  23. 23.
    Schmutzhard E, Stanek G, Pletschette M, Hirschl AM, Pallua A, Schmitzberger R, Schlögl R (1988) Infections following tickbites. Tick-borne encephalitis and Lyme borreliosis — a prospective epidemiological study from Tyrol. Infection 16:269–272Google Scholar
  24. 24.
    Stanek G, Flamm H, Groh V, Hirschl A, Kristoferitsch W, Neumann R, Schmutzhard E, Wewalka G (1986) Epidemiology of Borrelia infections in Austria. Zbl Bakt Hyg A 263:442–449Google Scholar
  25. 25.
    Steere AC (1989) Medical progress: Lyme disease. N Engl J Med 321:586–596Google Scholar
  26. 26.
    Steere AC, Schoen RT, Taylor E (1987) The clinical evolution of Lyme arthritis. Ann Intern Med 107:725–731Google Scholar
  27. 27.
    Steere AC, Bartenhagen NH, Craft JE, Hutchinson GJ, Newman JH, Pachner AR, Rahn DW, Sigal LH, Taylor E, Malawista SE (1986) Clinical manifestations of Lyme disease. Zbl Batk Hyg A 263:201–205Google Scholar
  28. 28.
    Steere AC, Green J, Schoen RT, Taylor E, Hutchinson GJ, Rahn DW, Malawista SE (1985) Successful parenteral penicillin therapy of established Lyme arthritis. N Engl J Med 312:869–874Google Scholar
  29. 29.
    Steere AC, Hutchinson GJ, Rahn DW, Sigal LH, Craft JE, De Sanna ET, Malawista SE (1983) Treatment of the early manifestation of Lyme disease. Ann Intern Med 99:22–26Google Scholar
  30. 30.
    Steere AC, Pachner AR, Malawista SE (1983) Neurologic abnormalities of Lyme disease: successful treatment with high-dose intravenous penicillin. Ann Intern Med 99:767–772Google Scholar
  31. 31.
    Steere AC, Batsford WP, Weinberg M, Alexander J, Berger HJ, Wolfson S, Malawista SE (1980) Lyme carditis: cardiac abnormalities of Lyme disease. Ann Intern Med 93:8–16Google Scholar
  32. 32.
    Steere AC, Broderick TF, Malawista SE (1978) Erythema chronicum migrans and Lyme arthritis: epidemiologic evidence for a tick vector. Am J Epidemiol 108:312–321Google Scholar
  33. 33.
    Steere AC, Malawista SE, Hardin JA, Ruddy S, Askenase PW, Andiman WA (1977) Erythema chronicum migrans and Lyme arthritis: the enlarging clinical spectrum. Ann Intern Med 86:685–698Google Scholar
  34. 34.
    Wilske B, Preac-Mursic V, Schierz G, Kühlbeck R, Barbour AG, Kramer M (1988) Antigenic variability ofBorrelia burgdorferi. Annals NY Acad Sci 539:126–143Google Scholar
  35. 35.
    Wilske B, Schierz G, Preac-Mursic V, Weber K, Pfister HW, Einhäupl K (1984) Serological diagnosis of erythema migrans disease and related disorders. Infection 12:331–337Google Scholar
  36. 36.
    Wilske B, Steinhuber R, Bergmeister H, Fingerle V, Schierz G, Preac-Mursic V, Vanek E, Lorbeer B (1977) Lyme Borreliose in Süddeutschland. Dtsch med Wochenschr 112:1730–1736Google Scholar
  37. 37.
    Wörth WD (1985) Therapie der Erythema-migrans-Krankheit (Lyme-Krankheit). Dtsch med Wochenschr 110:1379–1380Google Scholar
  38. 38.
    Weber K, Schierz G, Wilske B, Preac-Mursic V (1984) Zur Klinik und ätiologie der Acrodermatitis chronica atrophicans. Hautarzt 35:571–577Google Scholar

Copyright information

© Springer-Verlag 1990

Authors and Affiliations

  • W. Mayer
    • 1
  • F. X. Kleber
    • 1
  • B. Wilske
    • 2
  • V. Preac-Mursic
    • 2
  • W. Maciejewski
    • 1
  • H. Sigl
    • 1
  • E. Holzer
    • 1
  • W. Doering
    • 1
  1. 1.Krankenhaus München-SchwabingAkademisches Lehrkrankenhaus der Ludwig-Maximilians-Universität MünchenDeutschland
  2. 2.Max von Pettenkofer-Institut für Hygiene und Medizinische Mikrobiologie der Ludwig-Maximilians-Universität MünchenDeutschland

Personalised recommendations